Ongoing clinical trials and emerging agents in BCG-unresponsive NMIBC
Health Canada approves darolutamide for metastatic castration-sensitive prostate cancer
Vaginal estrogen tablets not linked with increased risk of recurrent ischemic stroke
Positive data on BOTRESO and MCS-8 highlight dual advances in prostate health
2 Commerce Drive
Cranbury, NJ 08512